Respiratory syncytial virus infection and prophylaxis with palivizumab in immunosuppressed children: The experience of a large Italian neonatal care setting

Saved in:
Bibliographic Details
Published inPediatric transplantation Vol. 11; no. 4; pp. 456 - 457
Main Authors Manzoni, Paolo, Leonessa, MariaLisa, Farina, Daniele, Gomirato, Giovanna
Format Journal Article
LanguageEnglish
Published Oxford, UK Blackwell Publishing Ltd 01.06.2007
Subjects
Antibodies, Monoclonal - therapeutic use
Antibodies, Monoclonal, Humanized
Antiviral Agents - therapeutic use
Humans
Immunocompromised Host
Immunologic Deficiency Syndromes - complications
Immunologic Deficiency Syndromes - immunology
Incidence
Infant, Newborn
Intensive Care, Neonatal
Italy - epidemiology
Palivizumab
Respiratory syncytial virus
Respiratory Syncytial Virus Infections - epidemiology
Respiratory Syncytial Virus Infections - etiology
Respiratory Syncytial Virus Infections - prevention & control
Respiratory Syncytial Viruses
Risk Factors
Treatment Outcome
Italy
Online AccessGet full text

Cover

More Information
Bibliography:ark:/67375/WNG-8ZRX5CN3-4
istex:CF5C8A8FD195D150CED3E9D0D9D8F33F28ED59FD
ArticleID:PETR672
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
SourceType-Other Sources-1
content type line 63
ObjectType-Correspondence-1
ObjectType-Commentary-2
ISSN:1397-3142
1399-3046
DOI:10.1111/j.1399-3046.2006.00672.x